Mona Sleiman, PHARM D | |
1919 N Amidon Ave Ste 220, Wichita, KS 67203-2120 | |
(316) 295-4721 | |
(316) 295-4724 |
Full Name | Mona Sleiman |
---|---|
Gender | Female |
Speciality | Pharmacist |
Location | 1919 N Amidon Ave Ste 220, Wichita, Kansas |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1235856535 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
183500000X | Pharmacist | 1-109630 (Kansas) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mona Sleiman, PHARM D 1919 N Amidon Ave Ste 220, Wichita, KS 67203-2120 Ph: (316) 295-4721 | Mona Sleiman, PHARM D 1919 N Amidon Ave Ste 220, Wichita, KS 67203-2120 Ph: (316) 295-4721 |
News Archive
High blood pressure may in some cases be caused by benign hormone-producing tumours of the adrenal cortex. A joint Swedish-American research effort has now uncovered a genetic cause behind the occurrence of such tumours. The findings were published today in the journal Science.
The School of Medicine at the University of California, Riverside has been awarded a grant of $3 million over a two-year period from health care provider Kaiser Permanente Southern California to increase the size and reach of the school's existing "pipeline programs" - a continuum of student enrichment and academic support programs - and thus broaden and diversify the pool of students applying to medical school.
Bowel Cancer UK welcomes the comments made by Mike Richards at the National Cancer Research Institute highlighting the lack of access to diagnostic tests for bowel cancer. Bowel Cancer UK has been campaigning on this issue for some time. The latest report from the charity, "Diagnosing bowel cancer early: right test, right time," highlights their concerns in more detail.
Affymax, Inc. and Takeda Global Research & Development Center, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, today announced preliminary top-line results from the Phase 3 clinical program for the investigational drug, Hematideā¢/peginesatide, for the treatment of anemia in chronic renal failure patients.
› Verified 7 days ago
Jennifer Howard, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1515 S Clifton Ave, Suite 100, Wichita, KS 67218 Phone: 316-689-6100 | |
Dr. Gage Gregory Swanson, PHARMD, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1402 S Ridge Road, Wichita, KS 67209 Phone: 316-945-7455 Fax: 316-945-7457 | |
Yvonne Elias-moussa, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1100 N Saint Francis Ave Ste 130, Wichita, KS 67214 Phone: 316-264-3505 Fax: 316-264-0978 | |
Dr. Jacob Arthur Doeden, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3707 N Woodlawn Blvd, Wichita, KS 67220 Phone: 316-691-9134 Fax: 316-691-9138 | |
Dr. Terry Bontrager, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3601 N Webb Rd, Wichita, KS 67226 Phone: 316-630-5350 Fax: 316-630-6349 | |
Jill Baalmann, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3311 E Murdock St, Wichita, KS 67208 Phone: 316-274-8280 | |
Cindy L Leddy, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5500 E Kellogg Dr, Wichita, KS 67218 Phone: 316-685-2221 |